Hong Kong—Sisram Medical Ltd (SISRAM MED) filed its Monthly Return for Equity Issuer for the period ended 31 July 2026, confirming that both authorised and issued share capital were unchanged during the month.

Key figures:

• Authorised share capital: 1.00 billion ordinary shares at a par value of ILS 0.01 each, equivalent to authorised capital of ILS 10.00 million. • Issued share capital: 468.34 million ordinary shares, representing 46.83 % of the authorised share count. • Treasury shares: Nil; no shares were repurchased, cancelled, or held in treasury. • Movements: The company recorded zero increases or decreases in authorised, issued, or treasury shares throughout July 2026.

Regulatory compliance:

• Sisram Medical affirmed that it meets the Main Board’s minimum public-float requirement of 25 % of issued shares. • No outstanding share options, warrants, convertible securities, or other equity-linked instruments were reported. • No Hong Kong Depositary Receipts are in issue.

The filing, submitted on 4 August 2026 by Company Secretary Qianli Fang, underscores Sisram Medical’s stable capital structure and ongoing compliance with Hong Kong Stock Exchange regulations.